BSX

Boston Scientific CorporationNYSEHealthcare

$62.82+1.32%OpenMarket Cap: $93.22B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-30	RBC Capital	—	Outperform	—
2026-03-30	Needham	—	Buy	—
2026-03-30	Raymond James	—	Outperform	—
2026-03-27	Goldman Sachs	—	Buy	—
2026-03-20	Stifel	—	Buy	—
2026-03-18	Truist Securities	—	Buy	—
2026-03-17	UBS	—	Buy	—
2026-03-11	Citigroup	—	Buy	—
2026-02-17	Canaccord Genuity	—	Buy	—
2026-02-09	BTIG	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$3.91	$24.59B	18
Sun Dec 31	$4.44	$27.09B	4
Mon Dec 31	$4.98	$29.74B	2
Tue Dec 31	$5.61	$33.07B	2